Invitation to presentation of Clavis Pharma's fourth quarter results 2009
(Thomson Reuters ONE) - Clavis Pharma ASA (OSE: CLAVIS) releases the company's fourth quarter 2009results on Wednesday 17 February 2010 at Hotel Continental, Stortingsgaten24/26, Oslo, Norway.The presentation will start at 08:30 (CET).Following the presentation, there will be a Q&A session.Breakfast will be servedfrom 08:00 hours (CET). Clavis Pharma welcomes all interested parties.The quarterly report and presentation will be available at the Oslo StockExchange,http://www.newsweb.no .ContactOlav Helleb?EOOffice: +47 24 11 09 65 / Mobile: +44 783 390 4901E-mail:olav.hellebo(at)clavispharma.com Gunnar Manum, CFOOffice: +47 24 11 09 71 / Mobile: +47 95 17 91 90E-mail:gunnar.manum(at)clavispharma.com For international press enquiries:Mark Swallow / Nina Enegren / David DibleCitigate Dewe RogersonOffice: +44 207 282 2948E-mail: clavispharma(at)citigatedr.co.uk DisclaimerThis news release contains forward-looking statements and forecasts based onuncertainty, since they relate to events and depend on circumstances that willoccur in the future and which, by their nature, will have an impact on resultsof operations and the financial condition of Clavis Pharma. There are a numberof factors that could cause actual results and developments to differ materiallyfrom those expressed or implied by these forward-looking statements. Thesefactors include, among other things, risks associated with technologicaldevelopment, the risk that research & development will not yield new productsthat achieve commercial success, the impact of competition, the ability to closeviable and profitable business deals, the risk of non-approval of patents notyet granted and difficulties of obtaining relevant governmental approvals fornew products.No expressed or implied representations or warranties are given concerningClavis Pharma or the accuracy or completeness of the information providedherein, and no claims shall be made by the recipient hereof by virtue of thisNews Announcement or the information contained herein.Clavis Pharma(TM) is a registered trademark of Clavis Pharma ASA.This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Securities Trading Act)[HUG#1384597]
Weitere Infos zu dieser Pressemeldung:Unternehmensinformation / Kurzprofil:Bereitgestellt von Benutzer: hugin
Datum: 15.02.2010 - 15:55 Uhr
Sprache: Deutsch
News-ID 12512
Anzahl Zeichen: 0
contact information:
Town:
Kategorie:
Diese Pressemitteilung wurde bisher
190 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"
Invitation to presentation of Clavis Pharma's fourth quarter results 2009"
steht unter der journalistisch-redaktionellen Verantwortung von
Clavis Pharma ASA
(
Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum
Haftungsauschluß (gemäß
TMG - TeleMedianGesetz) und dem
Datenschutz (gemäß der
DSGVO).
" alt="Can Can Lingerie Holding AG – Sale of non-core assets
